Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

Eli Lilly and Co. has begun selling its blockbuster weight-loss and diabetes drug Mounjaro in India, pipping rivals in a ...

The demand for glucagon-like peptide 1 (GLP-1) receptor agonists for overweight/obesity has created a clinical conundrum for ...

Can One Simple Hack Really Unlock Rapid Fat Loss? The Science Behind AquaSculpt’s Growing Popularity JUPITER, Fla., March 20, ...

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...

Protein has received widespread attention for weight loss thanks to its powerful role in building and maintaining ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

DEAR ERIC: I’ve been mentoring a young lady since she was in middle school. She’s in her early 30s now. She came from a very ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...